These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28933418)

  • 21. Current strategies in the management of lysosomal storage diseases.
    Heese BA
    Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.
    Hoffmann B; Mayatepek E
    Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysosomal storage diseases: Stem cell-based cell- and gene-therapy.
    Kim SU
    Cell Transplant; 2014 May; ():. PubMed ID: 24853878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral small molecule therapy for lysosomal storage diseases.
    Weinreb NJ
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():77-90. PubMed ID: 24380126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exacerbating and reversing lysosomal storage diseases: from yeast to humans.
    Rajakumar T; Munkacsi AB; Sturley SL
    Microb Cell; 2017 Aug; 4(9):278-293. PubMed ID: 28913343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in gene therapy for lysosomal storage disorders.
    Rastall DP; Amalfitano A
    Appl Clin Genet; 2015; 8():157-69. PubMed ID: 26170711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
    Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
    J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic approaches for lysosomal storage diseases: a patent update.
    Urbanelli L; Sagini K; Polidoro M; Brozzi A; Magini A; Emiliani C
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):91-109. PubMed ID: 23713988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The basics of lysosomal storage diseases].
    Tamò R; Rohrbach M; Baumgartner M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):199-207. PubMed ID: 30468118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases.
    Sánchez-Fernández EM; García Fernández JM; Mellet CO
    Chem Commun (Camb); 2016 Apr; 52(32):5497-515. PubMed ID: 27043200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic Screening and Diagnosis of Lysosomal Storage Diseases.
    Yu C; Sun Q; Zhou H
    N Am J Med Sci (Boston); 2013; 6(4):186-193. PubMed ID: 27293520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for lysosomal storage diseases: Current clinical trial prospects.
    Kido J; Sugawara K; Nakamura K
    Front Genet; 2023; 14():1064924. PubMed ID: 36713078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
    Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
    Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn screening of lysosomal storage disorders.
    Marsden D; Levy H
    Clin Chem; 2010 Jul; 56(7):1071-9. PubMed ID: 20489136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme replacement therapy for lysosomal storage diseases.
    Ohashi T
    Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():26-34. PubMed ID: 23330243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in therapeutic approaches for lysosomal storage diseases.
    Urbanelli L; Magini A; Polchi A; Polidoro M; Emiliani C
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocytes and lysosomal storage diseases.
    Rama Rao KV; Kielian T
    Neuroscience; 2016 May; 323():195-206. PubMed ID: 26037807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover.
    Pohl S; Angermann A; Jeschke A; Hendrickx G; Yorgan TA; Makrypidi-Fraune G; Steigert A; Kuehn SC; Rolvien T; Schweizer M; Koehne T; Neven M; Winter O; Velho RV; Albers J; Streichert T; Pestka JM; Baldauf C; Breyer S; Stuecker R; Muschol N; Cox TM; Saftig P; Paganini C; Rossi A; Amling M; Braulke T; Schinke T
    J Bone Miner Res; 2018 Dec; 33(12):2186-2201. PubMed ID: 30075049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of Enzyme Drugs Derived from Transgenic Silkworms to Treat Lysosomal Diseases].
    Itoh K; Nishioka SI; Hidaka T; Tsuji D; Maita N
    Yakugaku Zasshi; 2018; 138(7):885-893. PubMed ID: 29962464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.